Metabolomics Workbench : NIH Data Repository : Analyze Studies

Data for ST004206

(Analysis AN006995): Average values per metabolite and experimental factor (Units:normalized peak area)

Metabolite structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12
1-O-Palmitoyl-Cer(d18:1/18:0)	-	-	-	-	-	-	-	-	-	-	-	-
24-Hydroxycholesterol	-	-	-	-	-	-	-	-	-	-	-	-
24-Hydroxycholesterol(d7)	-	-	-	-	-	-	-	-	-	-	-	-
3-O-SulfoLacCer(d18:1/18:0)	0.00	-	-	0.00	-	0.00	-	0.00	-	-	0.00	-
4-beta-Hydroxycholesterol	-	-	-	-	-	-	-	-	-	-	-	-
7-keto-Cholesterol	-	-	-	-	-	-	-	-	-	-	-	-
CE(16:1)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CE(18:1)	0.12	0.14	0.13	0.11	0.12	0.12	0.13	0.12	0.14	0.12	0.11	0.12
CE(18:1(d7))	-	-	-	-	-	-	-	-	-	-	-	-
CE(18:2)	0.00	0.00	0.01	0.00	0.01	0.00	0.01	0.01	0.00	0.00	0.00	0.00
CE(20:4)	0.06	0.06	0.01	0.00	0.01	0.03	0.01	0.05	0.06	0.01	0.01	0.01
CE(20:5)	-	0.00	0.00	-	0.00	-	0.00	-	0.00	0.00	-	0.00
CE(22:6)	0.04	0.04	0.03	0.02	0.04	0.03	0.04	0.04	0.04	0.04	0.02	0.07
CE HETE	-	-	-	-	-	-	-	-	-	-	-	-
CE HODE	-	-	-	-	-	-	-	-	-	-	-	-
CE HpODE	-	-	-	-	-	-	-	-	-	-	-	-
CE oxoHETE	-	-	-	-	-	-	-	-	-	-	-	-
CE oxoODE	-	-	-	-	-	-	-	-	-	-	-	-
Cer(d18:0/16:0)	-	-	-	-	-	-	-	-	-	-	-	-
Cer(d18:0/18:0)	-	-	-	-	-	-	-	-	-	-	-	-
Cer(d18:0/24:0)	-	-	-	-	-	-	-	-	-	-	-	-
Cer(d18:0/24:1)	-	-	-	-	-	-	-	-	-	-	-	-
Cer(d18:1/16:0)	0.07	0.19	0.06	0.04	0.04	0.06	0.06	0.08	0.17	0.07	0.04	0.05
Cer(d18:1/16:0(d7))	-	-	-	-	-	-	-	-	-	-	-	-
Cer(d18:1/18:0)	0.17	0.38	0.14	0.06	0.08	0.12	0.10	0.16	0.34	0.15	0.07	0.08
Cer(d18:1/24:0)	0.09	0.17	0.13	0.07	0.12	0.08	0.12	0.10	0.15	0.14	0.08	0.14
Cer(d18:1/24:1)	0.20	0.38	0.22	0.11	0.15	0.16	0.21	0.20	0.32	0.24	0.12	0.18
Cholesterol	0.07	0.29	0.11	0.06	0.09	0.10	0.10	0.09	0.28	0.11	0.07	0.10
Cholesterol(d7)	-	-	-	-	-	-	-	-	-	-	-	-
Cholesteryl hexoside	-	-	-	-	-	-	-	-	-	-	-	-
Coenzyme Q10	-	-	-	-	0.00	-	-	-	-	-	0.00	0.00
DG(15:0/18:1(d7))	-	-	-	-	-	-	-	-	-	-	-	-
DG(16:0_18:1)	0.15	0.13	0.43	0.15	0.43	0.14	0.46	0.14	0.08	0.43	0.15	0.46
DG(16:0_20:4)	0.01	0.13	0.02	0.01	0.01	0.01	0.01	0.01	0.09	0.02	0.01	0.01
DG(18:0_18:1)	0.11	0.06	0.28	0.12	0.29	0.11	0.26	0.11	0.04	0.27	0.12	0.33
DG(18:0_20:4)	0.02	0.09	0.02	0.01	0.02	0.02	0.02	0.02	0.06	0.02	0.02	0.02
DG(18:0_22:6)	0.00	1.01	0.02	0.01	0.04	0.01	2.80	0.00	0.83	0.24	0.01	0.09
DG(18:1/18:1)	0.03	0.03	0.86	0.04	0.84	0.04	0.98	0.03	0.03	0.91	0.03	0.82
DG(18:1_20:4)	0.00	0.02	0.01	0.00	0.01	0.00	0.01	0.00	0.02	0.01	0.01	0.01
GB3(d18:1/16:0)	-	-	-	-	-	-	-	-	-	-	-	-
GB3(d18:1/18:0)	-	-	-	-	-	-	-	-	-	-	-	-
GB3(d18:1/18:0(d3))	-	-	-	-	-	-	-	-	-	-	-	-
GB3(d18:1/24:0)	-	-	-	-	-	-	-	-	-	-	-	-
GB3(d18:1/24:1)	-	-	-	-	-	-	-	-	-	-	-	-
GlcCer(d18:1/16:0(d3))	-	-	-	-	-	-	-	-	-	-	-	-
GlcCer(d18:1(d5)/18:0)	-	-	-	-	-	-	-	-	-	-	-	-
Glucosylsphingosine(d5)	-	-	-	-	-	-	-	-	-	-	-	-
HexCer(d18:1/12:0)	-	-	-	-	-	-	-	-	-	-	-	-
HexCer(d18:1/16:0)	0.01	0.01	0.00	0.01	0.00	0.01	0.00	0.01	0.01	0.00	0.01	0.00
HexCer(d18:1/18:0)	0.02	0.04	0.01	0.01	0.00	0.01	0.00	0.01	0.03	0.01	0.01	0.00
HexCer(d18:1/22:0)	0.03	0.06	0.01	0.03	0.01	0.03	0.01	0.03	0.05	0.02	0.03	0.02
HexCer(d18:1/24:0)	0.03	0.07	0.01	0.02	0.01	0.03	0.01	0.03	0.05	0.01	0.03	0.01
HexCer(d18:1/24:1)	0.07	0.15	0.02	0.04	0.02	0.06	0.02	0.06	0.12	0.02	0.06	0.02
Hexosylsphingosine	-	-	-	-	-	-	-	-	-	-	-	-
LacCer(d18:1/16:0)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LacCer(d18:1/17:0)	-	-	-	-	-	-	-	-	-	-	-	-
LacCer(d18:1/18:0)	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LacCer(d18:1/24:0)	-	0.00	0.00	0.00	0.00	-	0.00	-	0.00	0.00	0.00	0.00
LacCer(d18:1/24:1)	-	0.00	0.00	0.00	0.00	0.00	-	-	0.00	-	0.00	0.00
Lactosylsphingosine	-	-	-	-	-	-	-	-	-	-	-	-
LPC(16:0)	0.01	0.05	0.01	0.01	0.01	0.01	0.01	0.01	0.04	0.01	0.00	0.01
LPC(16:1)	-	0.00	-	-	-	-	-	0.00	0.00	-	0.00	-
LPC(18:0)	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00
LPC(18:1)	0.01	0.03	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01
LPC(18:1(d7))	-	-	-	-	-	-	-	-	-	-	-	-
LPC(20:4)	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00
LPC(22:6)	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LPC(24:0)	-	-	-	-	-	-	-	-	-	-	-	-
LPC(24:1)	-	-	-	-	-	-	-	-	-	-	-	-
LPC(26:0)	-	-	-	-	-	-	-	-	-	-	-	-
LPC(26:1)	0.00	-	0.00	-	0.00	-	0.00	-	-	0.00	0.00	0.00
lyso-GB3	-	-	-	-	-	-	-	-	-	-	-	-
lyso-GB3-d7	-	-	-	-	-	-	-	-	-	-	-	-
lyso-GB4	-	-	-	-	-	-	-	-	-	-	-	-
MG(16:0)	122.31	187.74	128.44	114.50	127.68	134.33	112.21	120.34	194.58	120.27	123.57	125.27
MG(16:1)	-	-	-	-	-	-	-	-	-	-	-	-
MG(18:0)	338.73	362.03	419.16	329.48	419.63	352.91	375.92	346.78	375.43	402.54	349.46	414.97
MG(18:1)	15.03	10.31	20.53	14.29	21.10	16.72	17.01	14.86	10.83	18.88	15.79	21.41
MG(18:1(d7))	-	-	-	-	-	-	-	-	-	-	-	-
MG(20:4)	-	-	-	-	-	-	-	-	-	-	-	-
N-Oleoylethanolamine	-	-	0.00	-	0.00	-	-	-	-	0.00	-	0.00
N-Palmitoyl-O-phosphocholineserine	-	-	-	-	-	-	-	-	-	-	-	-
Palmitoylethanolamine	-	0.00	0.00	-	0.00	-	0.00	-	0.00	0.00	-	0.00
PC(15:0/18:1(d7))	-	-	-	-	-	-	-	-	-	-	-	-
PC(16:0/5:0(CHO))	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00
PC(16:0/9:0(CHO))	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00
PC(16:0/9:0(COOH))	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PC(18:0/20:4(OH[S]))	-	-	-	-	-	-	-	-	-	-	-	-
PC(18:0/20:4(OOH[S]))	-	-	-	-	-	-	-	-	-	-	-	-
PC(34:1)	0.41	0.76	0.41	0.27	0.36	0.36	0.37	0.41	0.71	0.46	0.32	0.42
PC(36:1)	0.06	0.09	0.06	0.05	0.07	0.05	0.07	0.05	0.08	0.08	0.06	0.09
PC(36:2)	0.06	0.10	0.07	0.05	0.06	0.06	0.06	0.06	0.10	0.08	0.05	0.07
PC(36:4)	0.75	1.18	0.66	0.54	0.60	0.73	0.65	0.80	1.20	0.75	0.66	0.75
PC(38:4)	0.08	0.13	0.10	0.08	0.11	0.09	0.11	0.08	0.13	0.13	0.10	0.15
PC(38:6)	0.05	0.07	0.06	0.03	0.05	0.05	0.05	0.05	0.07	0.07	0.04	0.07
PC(40:5)	-	0.01	0.00	-	0.00	-	0.00	-	0.01	0.00	-	0.00
PC(40:6)	0.02	0.02	0.02	0.01	0.02	0.02	0.02	0.02	0.02	0.03	0.02	0.03
PC(O-16:0/0:0)	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00
PC(O-16:0/2:0)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PC(O-18:0/2:0)	-	-	-	-	-	-	-	-	-	-	-	-
PE(15:0/18:1(d7))	-	-	-	-	-	-	-	-	-	-	-	-
PE(18:0/20:4(OH[S]))	-	-	-	-	-	-	-	-	-	-	-	-
PE(18:0/20:4(OOH[S]))	-	-	-	-	-	-	-	-	-	-	-	-
PE(34:1)	0.16	0.52	0.16	0.07	0.10	0.11	0.13	0.15	0.47	0.17	0.08	0.11
PE(36:1)	0.12	0.33	0.12	0.09	0.12	0.10	0.12	0.10	0.28	0.13	0.11	0.14
PE(36:2)	0.14	0.32	0.17	0.07	0.13	0.11	0.16	0.13	0.29	0.19	0.08	0.14
PE(36:4)	0.24	0.57	0.25	0.10	0.15	0.18	0.23	0.26	0.57	0.28	0.12	0.19
PE(38:4)	0.47	1.05	0.61	0.37	0.57	0.44	0.63	0.50	1.08	0.74	0.46	0.70
PE(38:5)	0.13	0.26	0.18	0.08	0.15	0.11	0.21	0.14	0.27	0.22	0.10	0.19
PE(38:6)	0.64	1.17	0.78	0.27	0.47	0.47	0.68	0.63	1.16	0.81	0.31	0.53
PE(40:4)	0.07	0.15	0.08	0.05	0.07	0.06	0.08	0.07	0.15	0.09	0.05	0.08
PE(40:5)	-	-	-	-	-	-	-	-	-	-	-	-
PE(40:6)	0.50	1.16	0.79	0.42	0.80	0.46	0.86	0.49	1.20	0.96	0.51	0.89
PE(40:7)	0.22	0.31	0.31	0.11	0.22	0.17	0.34	0.22	0.32	0.36	0.14	0.25
Sitosteryl hexoside	-	-	-	-	-	-	-	-	-	-	-	-
SM(d18:1/16:0)	0.09	0.19	0.08	0.06	0.07	0.07	0.07	0.09	0.18	0.09	0.06	0.08
SM(d18:1/18:0)	0.04	0.12	0.05	0.03	0.04	0.03	0.04	0.04	0.11	0.05	0.03	0.05
SM(d18:1/24:0)	0.01	0.03	0.02	0.01	0.02	0.01	0.02	0.01	0.03	0.02	0.01	0.02
SM(d18:1/24:1)	0.06	0.15	0.07	0.05	0.07	0.05	0.06	0.06	0.14	0.07	0.05	0.08
SM(d18:1(d9)/18:1)	-	-	-	-	-	-	-	-	-	-	-	-
Sphinganine	-	-	-	-	-	-	-	-	-	-	-	-
Sphinganine 1-phosphate	-	-	-	-	-	-	-	-	-	-	-	-
Sphingosine	-	-	-	-	-	-	-	-	-	-	-	-
Sphingosine 1-phosphate	-	-	-	-	-	-	-	-	-	-	-	-
Sphingosine 1-phosphate-d7	-	-	-	-	-	-	-	-	-	-	-	-
Sphingosine 1-phosphocholine	-	-	-	-	-	-	-	-	-	-	-	-
Sphingosine(d17:1)	-	-	-	-	-	-	-	-	-	-	-	-
TG(15:0/18:1(d7)/15:0)	-	-	-	-	-	-	-	-	-	-	-	-
TG(18:0_36:2)	0.00	0.00	0.01	0.00	0.01	0.00	0.01	0.00	0.00	0.01	0.00	0.01
TG(18:1_34:2)	0.00	0.00	0.04	0.00	0.04	0.00	0.05	0.00	0.00	0.05	0.00	0.04
TG(18:1_34:3)	-	0.00	0.02	0.00	0.02	-	0.03	0.00	0.00	0.02	0.00	0.02
TG(20:4_32:1)	0.00	0.00	0.00	0.00	0.00	-	-	0.00	0.00	0.00	-	-
TG(20:4_34:2)	-	0.00	-	0.00	0.00	-	-	-	0.00	-	-	-
TG(20:4_34:3)	-	-	-	-	-	-	-	-	-	-	-	-
TG(20:4_36:0)	-	-	0.00	0.00	0.00	-	-	0.00	-	0.00	0.00	0.00
TG(20:4_36:2)	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TG(20:4_36:3)	0.00	0.00	0.00	0.00	-	-	-	0.00	0.00	-	-	-
TG(22:6_36:2)	0.00	-	0.00	0.00	0.00	0.00	-	0.00	-	0.00	0.00	0.00
TG(22:6_38:1)	-	-	-	-	-	-	-	-	-	-	-	-
TG(22:6_38:2)	-	-	-	-	-	-	-	-	-	-	-	-

Factors:

F1	Genotype:GPR34-KO \| Disease_State:APP-KI \| Age_months:16 months \| Sample source:Microglia
F2	Genotype:GPR34-KO \| Disease_State:APP-KI \| Age_months:24 months \| Sample source:Microglia
F3	Genotype:GPR34-KO \| Disease_State:APP-KI \| Age_months:4 months \| Sample source:Microglia
F4	Genotype:GPR34-KO \| Disease_State:APP-KI \| Age_months:8 months \| Sample source:Microglia
F5	Genotype:GPR34-KO \| Disease_State:WT \| Age_months:16 months \| Sample source:Microglia
F6	Genotype:GPR34-KO \| Disease_State:WT \| Age_months:4 months \| Sample source:Microglia
F7	Genotype:GPR34-KO \| Disease_State:WT \| Age_months:8 months \| Sample source:Microglia
F8	Genotype:NA \| Disease_State:NA \| Age_months:16 months \| Sample source:Microglia
F9	Genotype:NA \| Disease_State:NA \| Age_months:4 months \| Sample source:Microglia
F10	Genotype:NA \| Disease_State:NA \| Age_months:8 months \| Sample source:Microglia
F11	Genotype:WT \| Disease_State:APP-KI \| Age_months:16 months \| Sample source:Microglia
F12	Genotype:WT \| Disease_State:APP-KI \| Age_months:24 months \| Sample source:Microglia
F13	Genotype:WT \| Disease_State:APP-KI \| Age_months:4 months \| Sample source:Microglia
F14	Genotype:WT \| Disease_State:APP-KI \| Age_months:8 months \| Sample source:Microglia
F15	Genotype:WT \| Disease_State:WT \| Age_months:16 months \| Sample source:Microglia
F16	Genotype:WT \| Disease_State:WT \| Age_months:4 months \| Sample source:Microglia
F17	Genotype:WT \| Disease_State:WT \| Age_months:8 months \| Sample source:Microglia